Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Orally active carbapenem prodrug OCA-983 synthesized and evaluated at Wyeth-Ayerst

Aug. 10, 1999

Glaxo Wellcome files for approval of flu drug in Japan

Aug. 10, 1999

Avanir submits info on topical herpes treatment for final review

Aug. 10, 1999

Structurally unique beta-lactamase inhibitors reported by MethylGene, Wesleyan University

Aug. 9, 1999

Novel dual cephem-oxazolidinones described by Korean researchers

Aug. 6, 1999

Indian academic team identifies interesting new antibacterial compounds

Aug. 5, 1999

U.K.'s MCA is first to approve Synercid for marketing

Aug. 5, 1999

King Pharmaceuticals to acquire Lorabid from Lilly

Aug. 5, 1999

New erythromycin derivatives for treating infections caused by acid-fast bacteria

Aug. 4, 1999

Bristol-Myers Squibb describes lobucavir prodrugs with improved oral bioavailability

Aug. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.